2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
94
Leukemia, Myeloid, Chronic-Phase
25
Leukemia
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
15
Blast Crisis
9
Neoplasms
8
Neoplasm Metastasis
6
Philadelphia Chromosome
4
Myeloproliferative Disorders
4
Melanoma
4
Leukemia, Myeloid
4
Bone Marrow Diseases
4
Recurrence
3
Leukemia, Myeloid, Acute
3
Leukemia, Myeloid, Accelerated Phase
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Synovitis, Pigmented Villonodular
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Substance Withdrawal Syndrome
1
Sarcoma
1
Retroperitoneal liposarcoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Piebaldism
1
Peritoneal Neoplasms
1
Neurofibromatoses
1
Interventions
Cyclophosphamide
14
Dexamethasone
13
Vincristine
11
Cytarabine
11
Methotrexate
9
venetoclax
7
Inotuzumab Ozogamicin
7
Doxorubicin
7
pegaspargase
6
merphos
6
blinatumomab
6
Prednisone
6
dexamethasone acetate
5
dexamethasone 21-phosphate
5
Mercaptopurine
5
Calcium Dobesilate
5
prednylidene
4
deltacortene
4
azathiopurine
4
auricularum
4
Specimen Handling
4
Leucovorin
4
Asparaginase
4
Thioguanine
3
Rituximab
3
N,N-dicyclohexyl-isoborneol-10-sulfonamide
3
Methylprednisolone
3
fludarabine
2
calaspargase pegol
2
asparaginase erwinia chrysanthemi recombinant
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
×
nilotinib
×
Clear all
NCT00905398
2015-07-09
ALLPhi
Universidade Federal do Rio de Janeiro
Phase 1/2
Terminated
8 enrolled